Social media's allure for menopause relief masks dangers, and clinicians should know how to combat misinformation and provide education on marketed products that could put women at risk for harm.
Merck said on Friday a combination therapy being developed with partner Eisai failed a late-stage trial testing it as a first-line treatment for a type of cancer in the uterus lining.
Social and economic pressures have long compelled Black girls and women to straighten their hair. But mounting evidence shows chemical straighteners may pose cancer and other health risks.